Bupropion (Zyban) PGD for UK Pharmacies
Leading UK Pharmacies trust Deltera


















Provide access to Bupropion for smoking cessation. This PGD covers the 7–9 week course, with Deltera’s pre-screening focusing on seizure history and blood pressure monitoring for safe supply.
A Fully Digital Clinical Platform

Integrated Bookings and Payments

Secure & Connected Patient Records
Ditch the paperwork with secure digital records. Deltera automatically shares treatment summaries with the patient’s and sends the required notification to their GP instantly.


Training and Eligibility Requirements
To ensure clinical safety and regulatory compliance, all practitioners using this PGD must meet the following professional standards:
- Professional Registration: Must be a registered healthcare professional (e.g., Pharmacist) with a valid GPhC or PSNI registration and personal professional indemnity insurance.
- Clinical Competency: Practitioners must be self-certified as competent in the specific clinical area covered by this PGD and stay up to date with relevant national guidelines (e.g., The Green Book or NICE clinical summaries).
- Mandatory Training: Current certification in Basic Life Support (BLS) and the management of anaphylaxis is required for all injectable services.
- PGD Authorisation: The practitioner must have read and signed the PGD document within the Deltera Clinical Dashboard, with the authorisation counter-signed by the designated organisational lead or Superintendent.
- Premises Standards: Services must be conducted in a private consultation room that meets national standards for patient confidentiality and clinical safety.

Speak to the clinicians behind the platform
We understand the complexities of PGDs and clinical governance in the UK. Schedule a meeting with our team to see how we can help you navigate the changing landscape of community pharmacy.
Access related PGDs
FAQs
Patients with a history of seizures or eating disorders are typically excluded. Deltera’s "Red Flag" system highlights these contraindications during the digital pre-screen.
Yes. The PGD requires monitoring for hypertension. These readings can be recorded directly into the Deltera consultation notes for a perfect audit trail.
Usually set in the second week of treatment. Deltera’s portal provides the patient with advice on setting and sticking to their quit date for better results.
Absolutely. Deltera automates the GP notification to ensure they are aware of the medication and can monitor for potential drug interactions.
Still have questions?
Our team are here to support you.


Discover Deltera Practice Management
Deltera Practice Management digitalises your private pharmacy services, providing the complete pharmacy software package to offer a full range of Patient Group Directions (PGDs). Gain the oversight and efficiency you need to thrive.